title: Risk stratification in cardiac amyloidosis: novel approaches.
abstract: Amyloidosis is a term for diseases with extracellular deposition of insoluble beta-fibrillar proteins in different organs. The heart is primarily involved in more than half of patients with immunoglobulin light-chain amyloidosis or hereditary amyloidosis and associated with poor prognosis. Different traditional diagnostic tools that have been described for risk stratification lack of sufficient sensitivity and specificity for patient survival. Until November 2004 in 50 consecutive patients with light chain amyloidosis and 15 patients with hereditary amyloidosis electrocardiography, echocardiography, Holter monitoring, cardiopulmonary exercise test, lung function testing, tilt-test, and laboratory investigations have been performed at our department. Cardiac amyloidosis was found in 32 patients. Interventricular septum (14.3+/-0.5 mm vs. 12.3+/-0.7 mm, P<0.05), plasma NT-proBNP (7154+/-2122 ng/l vs. 380+/-113 ng/l; P<0.01), cardiac Troponin T (0.105+/-0.030 vs. 0.019+/-0.010 microg/l; P<0.05) were increased in patients with cardiac amyloidosis as compared to patients light chain amyloidosis but no cardiac involvement. Maximal inspiratory (Pimax) and expiratory (Pemax) mouth pressure were decreased with CA compared to controls. Correlation of NT-proBNP and interventricular septum thickness (r=0.53, P=0.029) as well as and Pimax (r=0.72, P<0.01) or Pemax (r=0.69; P<0.01) was noticed. A correlation of grade of arrhythmias in Holter monitoring and syncopes was not observed. Cardiac involvement of amyloid disease carries a poor prognosis and is not well characterized by classic heart failure determinants. Heart transplantation based on novel risk markers including NT-proBNP might be a suitable therapeutic approach for patients with manifest cardiac amyloidosis, but will require alternative patient selection and listing criteria.
authors.affiliation: Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Heidelberg, Germany. Arnt_Kristen@med.uni-heidelberg.de
authors.forename: Arnt V
authors.initials: AV
authors.lastname: Kristen
authors.forename: F Joachim
authors.initials: FJ
authors.lastname: Meyer
authors.forename: Jolanta B
authors.initials: JB
authors.lastname: Perz
authors.forename: Stefan O
authors.initials: SO
authors.lastname: Schonland
authors.forename: Michael
authors.initials: M
authors.lastname: Hundemer
authors.forename: Ute
authors.initials: U
authors.lastname: Hegenbart
authors.forename: Reinhard
authors.initials: R
authors.lastname: Singer
authors.forename: Philipp A
authors.initials: PA
authors.lastname: Schnabel
authors.forename: Falk-Udo
authors.initials: FU
authors.lastname: Sack
authors.forename: Hartmut
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: Hugo A
authors.initials: HA
authors.lastname: Katus
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Dengler
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis* / Q000276:immunology / Q000601:surgery*; D028226:Amyloidosis, Familial / Q000175:diagnosis / Q000601:surgery; D009202:Cardiomyopathies / Q000175:diagnosis* / Q000276:immunology / Q000601:surgery*; D004452:Echocardiography; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D016027:Heart Transplantation; D006801:Humans; D018570:Risk Assessment